Cargando…

NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study

Recently, 2 studies from Thai and American investigated the relationship between NAD(P)H: quinone oxidoreductase 1(NQO1) gene rs1800566 polymorphism and cervical cancer risk and generated contrary results. However, no Chinese reports have addressed this relationship until now. To explore the associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shanshan, Zhao, Jiannan, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5600
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253782/ https://www.ncbi.nlm.nih.gov/pubmed/32443295 http://dx.doi.org/10.1097/MD.0000000000019941

Ejemplares similares

Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls
por: Zhou, Hangsheng, et al.
Publicado: (2022)

NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
por: Lee, Junguee, et al.
Publicado: (2013)

The FTO rs9939609 and LEPR rs1137101 mothers–newborns gene polymorphisms and maternal fat mass index effects on anthropometric characteristics in newborns: A cross-sectional study on mothers–newborns gene polymorphisms—The FTO-LEPR Study (STROBE-compliant article)
por: Mărginean, Claudiu, et al.
Publicado: (2016)

CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis
por: Hu, ShiWan, et al.
Publicado: (2020)

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
por: Traver, R. D., et al.
Publicado: (1997)

The association between rs1800872 polymorphism in interleukin-10 and risk of cervical cancer: A meta-analysis
por: Wang, Kexin, et al.
Publicado: (2021)

Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
por: Glorieux, Christophe, et al.
Publicado: (2019)

Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family
por: Vasiliou, Vasilis, et al.
Publicado: (2006)

Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Association of FCRL3 Genetic Polymorphisms With Endometriosis-Related Infertility Risk: An Independent Study in Han Chinese
por: Zhang, Haiyan, et al.
Publicado: (2015)

Analysis of risk factors for cesarean scar diverticulum: A STROBE-compliant case-control study
por: Liu, Songjun, et al.
Publicado: (2021)

Red blood cell indices as an effective marker for the existence and severity of endometriosis (STROBE)
por: Cho, Hye-Yon, et al.
Publicado: (2022)

Riboflavin compounds show NAD(P)H dependent quinone oxidoreductase-like quinone reducing activity
por: Nagase, Midori, et al.
Publicado: (2023)

Identification of NAD(P)H Quinone Oxidoreductase Activity in Azoreductases from P. aeruginosa: Azoreductases and NAD(P)H Quinone Oxidoreductases Belong to the Same FMN-Dependent Superfamily of Enzymes
por: Ryan, Ali, et al.
Publicado: (2014)

Factors predicting clinical pregnancy rate of in vitro fertilization-embryo transfer (a STROBE-compliant article)
por: Zhang, Yi-Le, et al.
Publicado: (2019)

Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study
por: Xu, Hong-Yu, et al.
Publicado: (2020)

STROBE-sequencing analysis of the vaginal microecology of 4- to 6-year-old girls in Southwest China
por: Zhang, Yiduo, et al.
Publicado: (2021)

Structural Insights into the NAD(P)H:Quinone Oxidoreductase from Phytophthora capsici
por: Yang, Cancan, et al.
Publicado: (2022)

Clinical characteristics of fetal and neonatal outcomes in twin pregnancy with preeclampsia in a retrospective case–control study: A STROBE-compliant article
por: Yuan, Ting, et al.
Publicado: (2016)

Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations
por: den Braver-Sewradj, Shalenie P., et al.
Publicado: (2017)

Identification of SEPP1 polymorphisms is not a genetic risk factor for preeclampsia in Chinese Han women: A clinical trial and experimental study
por: Wu, Hong, et al.
Publicado: (2017)

Gestational obesity and subclinical inflammation: The pathway from simple assessment to complex outcome (STROBE-compliant article)
por: Rugină, Cosmin, et al.
Publicado: (2021)

Systemic inflammatory status – a bridge between gestational weight gain and neonatal outcomes (STROBE-compliant article)
por: Rugină, Cosmin, et al.
Publicado: (2021)

Prophylactic intraoperative uterine or internal iliac artery embolization in planned cesarean for pernicious placenta previa in the third trimester of pregnancy: An observational Study (STROBE compliant)
por: Wang, Juan, et al.
Publicado: (2019)

Influence of NQO1 Polymorphisms on Warfarin Maintenance Dose: A Systematic Review and Meta-Analysis (rs1800566 and rs10517)
por: Tian, Lihong, et al.
Publicado: (2021)

NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis
por: Agúndez, José A G, et al.
Publicado: (2014)

PTX3 Gene 3’UTR polymorphism and its interaction with environmental factors are correlated with the risk of preeclampsia in a Chinese Han population
por: Xu, Ning, et al.
Publicado: (2020)

Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article)
por: Yang, Yan, et al.
Publicado: (2019)

A prospective observational study evaluating the efficacy of prophylactic internal iliac artery balloon catheterization in the management of placenta previa–accreta: A STROBE compliant article
por: Fan, Yao, et al.
Publicado: (2017)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
por: Stoehr, Christine G., et al.
Publicado: (2012)

Polymorphic variants conferring genetic risk to cervical lesions support GSTs as important associated loci
por: Tian, Sijuan, et al.
Publicado: (2019)

Effects of sequential paclitaxel–carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study
por: Wang, Fei, et al.
Publicado: (2016)

NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives
por: Ghorab, Mostafa M, et al.
Publicado: (2016)

Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?
por: Cao, Lei, et al.
Publicado: (2023)

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.
por: Kelsey, K. T., et al.
Publicado: (1997)

Comparisons on perinatal depression between the first-child women and the second-child women in West China under the universal 2-child policy: A STROBE compliant prospective cohort study
por: Guo, Xiu-Jing, et al.
Publicado: (2020)

Impact of demographic, genetic, and bioimpedance factors on gestational weight gain and birth weight in a Romanian population: A cross-sectional study in mothers and their newborns: the Monebo study (STROBE-compliant article)
por: Mărginean, Claudiu, et al.
Publicado: (2016)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells
por: Siegel, David, et al.
Publicado: (2012)

Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents
por: Zeekpudsa, Ponsilp, et al.
Publicado: (2014)

The potential roles of NAD(P)H:quinone oxidoreductase 1 in the development of diabetic nephropathy and actin polymerization
por: Moon, Sung-Je, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s11fs2sjf868lhmd8fvbleerc4